Trident Texofab Ltd - 540726 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Chetan Chandrakant Jariwala Trident Texofab Ltd - 540726 - Disclosure Under Regulation 29(2) And (3) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Trident Texofab Limited has submitted disclosure received from Mr. Chetan Chandrakant Jariwala in terms of sub regulation (2) & (3) of regulation 29 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in the format prescribed. This is for your information and record. Thank you. Trident Texofab Ltd - 540726 - Commencement Of Commercial Production/Operations From Shuttle Less Brand New Flexible Rapier Loom At Hojiwala, Sachin, Surat-Disclosure Of Event/ Information As Per Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Company has informed to the Stock Exchange that it has started its commercial production/operations from the Shuttle Less Brand New Flexible Rapier Loom at the Manufacturing unit of the Company situated at Plot No. B-15/11, Hojiwala Industrial Estate, Sachin Palsana Road, Surat-394230, Gujarat w.e.f today. Kindly take on your record. Thank You, Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Investor Presentation
Trident Texofab Limited has submitted revised Earnings Presentation for the third quarter and nine months ended on December 31, 2020(Q3FY21). The revised Earning Presentation is being attached herewith. Kindly take the above on record. Thank you. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Investor Presentation
Trident Texofab Limited has submitted Earning Presentation for the third quarter and nine months ended on December 31, 2020 (Q3FY21). Kindly take the above on record. Thank you. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Trident Texofab Limited has submitted newspaper publication of Extract of Unaudited Standalone Financial Results for the Quarter and Nine Months ended 31st December,2020. A copy of the same is attached for your information and records. The same is available on the Company's website www.tridenttexofab.com Thank You Trident Texofab Ltd - 540726 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31, 2020 Along With Limited Review Report
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held on today i.e. February 11, 2021 commenced at 03.00 p.m. and concluded at 04.10 p.m. at the registered office of the Company have inter-alia considered, approved and taken on record including the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2020 along with Limited Review Report for the quarter and nine months ended on December 31, 2020 carried out by the Statutory Auditors of the Company. Trident Texofab Ltd - 540726 - Board Meeting Outcome
Trident Texofab Limited has submitted Board Meeting Outcome held on today at 03:00 p.m and concluded at 04:10 p.m where the unaudited Financial results of the Company for the Quarter and nine months ended on December 31,2020 considered, approved and taken on record. Please find enclosed a copy of the above Unaudited Financial Results & Limited Review Report. Thank You. Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Trident Texofab Limited has submitted Newspaper Advertisements of Notice of Board Meeting of the Company to be held on 11th February, 2021. A copy of the same is attached for your information and records. Kindly take the above on record. Thank you. Trident Texofab Ltd - 540726 - Board Meeting Intimation for Consideration And Approval Including The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31, 2020
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve including 1.The Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2020.